AI cardiac digital twins challenge sex-specific care

The Conversation reports that AI-powered "digital twins" for cardiology are being developed as patient-specific computer models that combine medical imaging, clinical records and biological data to simulate disease progression and to test treatment strategies virtually. The article notes that proponents see digital cardiac twins as a route to more precise, noninvasive monitoring and early detection. The Conversation highlights a concern: if the medical datasets used to build these virtual hearts omit sex-specific biological differences, the resulting models may be incomplete when applied to women.

Editorial analysis - technical context: Digital cardiac twin workflows typically fuse multiple data modalities during model construction, for example:

• •imaging (echocardiography, CT, MRI)
• •clinical records (diagnoses, medications, outcomes)
• •molecular or physiological data (biomarkers, immune markers)

Editorial analysis: In practice, model fidelity depends on the representativeness of these inputs and on whether sex is encoded as a biological variable rather than a simple demographic label. The Conversation's article references emerging research that documents sex differences in immune responses and cardiovascular physiology, which could alter both disease presentation and modelled treatment responses.

Industry context: For clinicians and ML practitioners, this is a reminder that translational AI in healthcare faces two linked risks: dataset bias and incompletely specified biological covariates. Models trained on mixed or underrepresentative cohorts can underperform on subpopulations. Regulators and clinical trial designs that require subgroup analysis increasingly surface these issues, and validation across sex-disaggregated cohorts is becoming a de facto expectation in clinical AI evaluation.

For practitioners and researchers: monitor publication of sex-disaggregated cardiac datasets, preprints or trials that evaluate digital twins separately by sex, and guidance from regulators or standards bodies on subgroup validation. Also watch for method papers proposing principled incorporation of sex-specific physiology into mechanistic or hybrid (mechanistic+ML) twin architectures.